Often, pharmaceutical companies avoid new laboratory testing methodologies preferring to stick to established procedures for drug development so as to avoid any potential regulatory ambiguity. This tendency to avoid new methodologies and regulatory scrutiny sometimes leads to slower progress, higher costs and lower probability of new product approvals. Furthermore, some pharmaceutical firms severely restrict academic research-based modifications to established laboratory testing procedures in drug development because of their concern over triggering costly adjustments to the established regulatory framework.
KMH Cardiology Center is a healthcare provider based in Canada that offers patient-centric healthcare services. It began with one facility in 1988 and has since expanded to 11 locations across the Greater Toronto Area (GTA) and Southwestern Ontario. KMH provides a variety of diagnostic services, including Nuclear Medicine, Cardiology, Positron Emission Tomography (PET), and Magnetic Resonance Imaging (MRI), and also offers in-person and virtual consultations with Cardiologists and Internal Medicine specialists. With a commitment to quality and a patient-focused approach, KMH is a trusted and reliable healthcare partner in each of the communities it serves.
Located in Toronto, Clairhurst Ultrasound and X-Ray specializes in X-Ray, Diagnostics and Ultrasound services for medical and dental needs. Contact us today for an appointment or drop in to our clinic at Bathurst and St. Clair.